Study of Lung Function in Children Who Have Undergone Bone Marrow Transplantation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

280 participants

Study Classification

OBSERVATIONAL

Study Start Date

1996-03-31

Study Completion Date

2005-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

RATIONALE: Assessing the long-term effects of bone marrow transplant on lung function in patients may improve the ability to plan treatment.

PURPOSE: This clinical trial studies lung function in pediatric patients who have undergone bone marrow transplant.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer

NCT00126477

Leukemia Lymphoma Myelodysplastic Syndromes +1 more

COMPLETED

Prospective Study of Belated Pulmonary Complications Occurring in Children Treated With Allogeneic Hematopoietic Stem Cells.

NCT02032381

Bone Marrow Transplant Infection Bronchiolitis Obliterans Chronic Respiratory Insufficiency +2 more

COMPLETED NA

Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies

NCT02338479

Acute Lymphoblastic Leukemia/Lymphoma Myelodysplasia Acute Myelogenous Leukemia +2 more

UNKNOWN

Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation

NCT03000244

Hematopoietic Stem Cell Transplantation Tissue Donors

RECRUITING

Pulmonary Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation

NCT01420172

Post Hematopoietic Stem Cell Transplantation

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

OBJECTIVES:

* Determine the delayed effects of bone marrow transplantation preparative regimens on pulmonary function in children surviving at least 5 years after transplantation for hematologic malignancy.
* Determine the relationship between pulmonary function and growth rates in these patients.
* Determine the effect of growth hormone treatment on pulmonary function in these patients.
* Determine the relationship between pulmonary function and age at time of transplantation in these patients.
* Determine the incidence and severity of restrictive pulmonary disease, and whether these factors vary with increasing time after transplantation in these patients.

OUTLINE: Patients undergo respiratory history, signs and symptoms assessment, pulmonary function tests (PFT) including spirometry, lung volumes, and diffusion, oxygen saturation by pulse oximetry, and height measurement.

Patients are assessed at 5-10 years, 10-15 years, and over 15 years after bone marrow transplantation. Patients with abnormal PFTs are assessed at more frequent intervals as clinically indicated.

PROJECTED ACCRUAL: Approximately 280 patients will be accrued for this study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Long-term Effects Secondary to Cancer Therapy in Children Pulmonary Complications

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

management of therapy complications

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

DISEASE CHARACTERISTICS:

* Patients who have undergone bone marrow transplantation for hematologic malignancy at least 5 years ago

* Disease-free survivors at least 6 years of age AND
* Under 18 years of age at time of transplantation
* Received prior allogeneic, unrelated donor, syngeneic, or autologous bone marrow transplantation
* Able to perform pulmonary function tests

PATIENT CHARACTERISTICS:

Age:

* See Disease Characteristics

Performance status:

* Not specified

Life expectancy:

* Not specified

Hematopoietic:

* Not specified

Hepatic:

* Not specified

Renal:

* Not specified

PRIOR CONCURRENT THERAPY:

Biologic therapy:

* See Disease Characteristics

Chemotherapy:

* Not specified

Endocrine therapy:

* Not specified

Radiotherapy:

* Not specified

Surgery:

* Not specified

Other:

* Any prior preparative regimen allowed

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No